m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma

被引:71
作者
Du, Jianyang [1 ]
Ji, Hang [1 ]
Ma, Shuai [1 ]
Jin, Jiaqi [1 ]
Mi, Shan [1 ]
Hou, Kuiyuan [1 ]
Dong, Jiawei [1 ]
Wang, Fang [1 ]
Zhang, Chaochao [3 ]
Li, Yuan [2 ]
Hu, Shaoshan [1 ]
机构
[1] Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 2, 157 Baojian Rd, Harbin 150086, Peoples R China
[2] Shandong Univ, Cheeloo Coll Med, Sch Pharmaceut Sci, Dept Pharmacol, Jinan 250012, Shandong, Peoples R China
[3] First Hosp Jilin Univ, Dept Neurosurg, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
m6A; tumor immune microenvironment; stemness; machine learning; immunotherapy; pan-cancer; M(6)A MODIFICATION; IMMUNOTHERAPY; LEUKEMIA; FEATURES; RNAS;
D O I
10.1093/bib/bbab013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
m6A RNA methylation is an emerging epigenetic modification, and its potential role in immunity and sternness remains unknown. Based on 17 widely recognized m6A regulators, the m6A modification patterns and corresponding characteristics of immune infiltration and sternness of 1152 low-grade glioma samples were comprehensively analyzed. Machine-learning strategies for constructing m6AScores were trained to quantify the m6A modification patterns of individual samples. Here, we reveal a significant correlation between the multi-omics data of regulators and clinicopathological parameters. We identified two distinct m6A modification patterns (an immune-activated differentiation pattern and an immune-desert dedifferentiation pattern) and four regulatory patterns of m6A methylation on immunity and sternness. We show that the m6AScores can predict the molecular subtype of low-grade glioma, the abundance of immune infiltration, the enrichment of signaling pathways, gene variation and prognosis. The concentration of high immunogenicity and clinical benefits in the low-m6AScore group confirmed the sensitive response to radio-chemotherapy and immunotherapy in patients with high-m6AScore. The results of the pan-cancer analyses illustrate the significant correlation between m6AScore and clinical outcome, the burden of neoepitope, immune infiltration and sternness. The assessment of individual tumor m6A modification patterns will guide us in improving treatment strategies and developing objective diagnostic tools. [GRAPHICS] .
引用
收藏
页数:17
相关论文
共 51 条
[1]   Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control [J].
Barbieri, Isaia ;
Tzelepis, Konstantinos ;
Pandolfini, Luca ;
Shi, Junwei ;
Millan-Zambrano, Gonzalo ;
Robson, Samuel C. ;
Aspris, Demetrios ;
Migliori, Valentina ;
Bannister, Andrew J. ;
Han, Namshik ;
De Braekeleer, Etienne ;
Ponstingl, Hannes ;
Hendrick, Alan ;
Vakoc, Christopher R. ;
Vassiliou, George S. ;
Kouzarides, Tony .
NATURE, 2017, 552 (7683) :126-+
[2]   N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing [J].
Bartosovic, Marek ;
Molares, Helena Covelo ;
Gregorova, Pavlina ;
Hrossova, Dominika ;
Kudla, Grzegorz ;
Vanacova, Stepanka .
NUCLEIC ACIDS RESEARCH, 2017, 45 (19) :11356-11370
[3]   Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma [J].
Ceccarelli, Michele ;
Barthel, Floris P. ;
Malta, Tathiane M. ;
Sabedot, Thais S. ;
Salama, Sofie R. ;
Murray, Bradley A. ;
Morozova, Olena ;
Newton, Yulia ;
Radenbaugh, Amie ;
Pagnotta, Stefano M. ;
Anjum, Samreen ;
Wang, Jiguang ;
Manyam, Ganiraju ;
Zoppoli, Pietro ;
Ling, Shiyun ;
Rao, Arjun A. ;
Grifford, Mia ;
Cherniack, Andrew D. ;
Zhang, Hailei ;
Poisson, Laila ;
Carlotti, Carlos Gilberto, Jr. ;
Tirapelli, Daniela Pretti da Cunha ;
Rao, Arvind ;
Mikkelsen, Tom ;
Lau, Ching C. ;
Yung, W. K. Alfred ;
Rabadan, Raul ;
Huse, Jason ;
Brat, Daniel J. ;
Lehman, Norman L. ;
Barnholtz-Sloan, Jill S. ;
Zheng, Siyuan ;
Hess, Kenneth ;
Rao, Ganesh ;
Meyerson, Matthew ;
Beroukhim, Rameen ;
Cooper, Lee ;
Akbani, Rehan ;
Wrensch, Margaret ;
Haussler, David ;
Aldape, Kenneth D. ;
Laird, Peter W. ;
Gutmann, David H. ;
Noushmehr, Houtan ;
Iavarone, Antonio ;
Verhaak, Roel G. W. .
CELL, 2016, 164 (03) :550-563
[4]   The role of m6A RNA methylation in human cancer [J].
Chen, Xiao-Yu ;
Zhang, Jing ;
Zhu, Jin-Shui .
MOLECULAR CANCER, 2019, 18 (1)
[5]   m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells [J].
Cui, Qi ;
Shi, Hailing ;
Ye, Peng ;
Li, Li ;
Qu, Qiuhao ;
Sun, Guoqiang ;
Sun, Guihua ;
Lu, Zhike ;
Huang, Yue ;
Yang, Cai-Guang ;
Riggs, Arthur D. ;
He, Chuan ;
Shi, Yanhong .
CELL REPORTS, 2017, 18 (11) :2622-2634
[6]   The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells [J].
Dixit, Deobrat ;
Prager, Briana C. ;
Gimple, Ryan C. ;
Poh, Hui Xian ;
Wang, Yang ;
Wu, Qiulian ;
Qiu, Zhixin ;
Kidwell, Reilly L. ;
Kim, Leo J. Y. ;
Xie, Qi ;
Vitting-Seerup, Kristoffer ;
Bhargava, Shruti ;
Dong, Zhen ;
Jiang, Li ;
Zhu, Zhe ;
Hamerlik, Petra ;
Jaffrey, Samie R. ;
Zhao, Jing Crystal ;
Wang, Xiuxing ;
Rich, Jeremy N. .
CANCER DISCOVERY, 2021, 11 (02) :480-499
[7]   Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq [J].
Dominissini, Dan ;
Moshitch-Moshkovitz, Sharon ;
Schwartz, Schraga ;
Salmon-Divon, Mali ;
Ungar, Lior ;
Osenberg, Sivan ;
Cesarkas, Karen ;
Jacob-Hirsch, Jasmine ;
Amariglio, Ninette ;
Kupiec, Martin ;
Sorek, Rotem ;
Rechavi, Gideon .
NATURE, 2012, 485 (7397) :201-U84
[8]   The Emerging Roles of RNA Modifications in Glioblastoma [J].
Dong, Zhen ;
Cui, Hongjuan .
CANCERS, 2020, 12 (03)
[9]   Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices [J].
Du, Jianyang ;
Yan, Xiuwei ;
Mi, Shan ;
Li, Yuan ;
Ji, Hang ;
Hou, Kuiyuan ;
Ma, Shuai ;
Ba, Yixu ;
Zhou, Peng ;
Chen, Lei ;
Xie, Rui ;
Hu, Shaoshan .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
[10]   Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma [J].
Du, Jianyang ;
Hou, Kuiyuan ;
Mi, Shan ;
Ji, Hang ;
Ma, Shuai ;
Ba, Yixu ;
Hu, Shaoshan ;
Xie, Rui ;
Chen, Lei .
FRONTIERS IN ONCOLOGY, 2020, 10